(Q40025709)

English

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

scientific article published on November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

cervix uterine cancer

1 reference

based on heuristic

inferred from title

object named as

Mireia Diaz

3

0 references

1

object named as

Sue J Goldie

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Meredith O'Shea

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sun-Young Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Reproductive Health Matters

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

86-96

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Chapter 2: The burden of HPV-related cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Chapter 8: Screening for cervical cancer in developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Cost-effectiveness of cervical-cancer screening in five developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Chapter 19: Cost-effectiveness of cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

A critical assessment of screening methods for cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Modeling cervical cancer prevention in developed countries

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Mathematical models of cervical cancer prevention in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Methods to assess the costs and health effects of interventions for improving health in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Multiparameter Calibration of a Natural History Model of Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Estimating the cost of cervical cancer screening in five developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

21 January 2018

Chapter 15: Public health policy and cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

7 January 2021

based on heuristic

inferred from DOI database lookup

[Economic impact of rotavirus vaccination in Panama]

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Introducing HPV vaccine in developing countries--key challenges and issues

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human Papillomavirus Vaccination — Reasons for Caution

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2808%2932409-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0968-8080(08)32409-4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40025709&oldid=2043428320"